Skip to content
OpenCapital
Get started

Amphastar Pharmaceuticals AMPH Balance Sheet Statement

Income StatementBalance SheetCash FlowRatiosSegments
QuarterlyAnnualTTM
YoYQoQ
SimplifiedDetailed
TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Cash and cash equivalents
$170.94M+0.4%$170.18M-21.3%$216.27M+15.2%$187.69M+2.7%$182.78M+20.6%
Short-term investments
$121.01M+7.4%$112.64M+87.9%$59.94M+36.0%$44.06M-18.6%$54.1M-22.8%
Restricted cash
$235K0.0%$235K0.0%$235K0.0%$235K0.0%$235K0.0%
Accounts receivable, net
$147.85M+3.0%$143.56M-2.2%$146.81M+10.4%$132.98M-8.1%$144.64M+6.1%
Inventories
$170.19M-3.8%$176.89M-4.9%$185.93M-3.0%$191.73M+3.4%$185.48M+20.6%
Prepaid expenses and other current assets
$11.65M-11.4%$13.15M-49.5%$26.02M+28.0%$20.33M+14.4%$17.77M-2.4%
Total current assets
$633.68M-0.4%$636.02M-0.5%$639.47M+10.1%$580.83M-1.2%$587.96M+10.1%
Property and equipment, net
$307.23M-1.1%$310.57M+0.6%$308.69M-0.5%$310.24M+0.9%$307.6M+3.4%
Operating lease right-of-use assets
$71.5M+66.5%$42.93M-3.7%$44.58M+0.9%$44.2M-3.5%$45.82M-2.3%
Goodwill
$559.62M-1.1%$565.97M-1.1%$572.24M-1.1%$578.5M-1.0%$584.53M-1.0%
Other non-current assets
$33.48M+7.5%$31.14M+4.2%$29.87M+6.3%$28.1M+22.2%$22.99M-11.5%
Total assets
$1.65B+1.2%$1.63B-2.2%$1.67B+3.2%$1.62B-0.7%$1.63B+3.1%
Accounts payable
$152.69M+2.9%$148.35M-22.3%$190.84M+14.6%$166.55M-5.3%$175.94M+12.0%
Current portion of long-term debt
$1.67M+1.8%$1.64M+77.8%$923K-0.4%$927K+314%$224K-4.3%
Operating lease liabilities, current
$9.71M+22.4%$7.93M+1.3%$7.83M-0.7%$7.88M+1.7%$7.75M+13.8%
Total current liabilities
$164.48M+4.0%$158.16M-22.9%$205.23M+16.3%$176.41M-11.4%$199.05M+14.6%
Long-term debt
$609.8M+0.2%$608.75M0.0%$608.58M+0.1%$607.73M+0.6%$603.86M+0.4%
Operating lease liabilities, non-current
$65.2M+73.0%$37.68M-4.5%$39.44M+1.2%$38.96M-4.3%$40.71M-2.8%
Operating Lease Liabilities (Total)
——————————
Finance lease liabilities
$232K-12.1%$264K-12.3%$301K-12.8%$345K-9.7%$382K-11.6%
Other non-current liabilities
$29.37M-2.0%$29.98M+2.4%$29.27M+5.3%$27.8M+13.8%$24.42M+16.6%
Total liabilities
$874.77M+4.1%$840.49M-5.5%$889.48M+3.7%$857.85M-2.0%$874.99M+3.5%
Common stock
$6K0.0%$6K0.0%$6K0.0%$6K0.0%$6K0.0%
Additional paid-in capital
$543.82M+1.6%$535.38M+1.5%$527.22M+1.3%$520.58M+2.3%$509.11M+0.7%
Retained earnings
$673.3M+1.0%$666.88M+3.8%$642.45M+2.8%$625.1M+5.2%$594.07M+4.4%
Accumulated other comprehensive income (loss)
-$5.74M-7.9%-$5.31M-0.8%-$5.27M+1.6%-$5.36M+32.7%-$7.97M+13.2%
Treasury stock
$438M+7.3%$408.15M+5.3%$387.65M+1.3%$382.85M+11.3%$343.93M+3.4%
Total liabilities and stockholders' equity
$1.65B+1.2%$1.63B-2.2%$1.67B+3.2%$1.62B-0.7%$1.63B+3.1%
Income Tax Refund And Deposits
$9.61M-44.0%$17.17M+731%$2.07M+28.8%$1.6M+111%$758K-56.6%
Short-term restricted investments
$2.2M0.0%$2.2M0.0%$2.2M0.0%$2.2M0.0%$2.2M0.0%
Deferred Tax Assets and Other Non-Current Assets
$33.48M+7.5%$31.14M+4.2%$29.87M+6.3%$28.1M+22.2%$22.99M-11.5%
Goodwill and Intangible Assets, Net
$559.62M-1.1%$565.97M-1.1%$572.24M-1.1%$578.5M-1.0%$584.53M-1.0%
Net Investment in Lease
$71.5M+66.5%$42.93M-3.7%$44.58M+0.9%$44.2M-3.5%$45.82M-2.3%
Deferred tax assets
$42.46M0.0%$42.46M-40.3%$71.12M0.0%$71.12M0.0%$71.12M0.0%
Goodwill and intangible assets, net
$559.62M-1.1%$565.97M-1.1%$572.24M-1.1%$578.5M-1.0%$584.53M-1.0%
Operating lease right-of-use assets
$71.5M+66.5%$42.93M-3.7%$44.58M+0.9%$44.2M-3.5%$45.82M-2.3%
Other non-current assets
$33.48M+7.5%$31.14M+4.2%$29.87M+6.3%$28.1M+22.2%$22.99M-11.5%
Short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84)
$121.01M+7.4%$112.64M+87.9%$59.94M+36.0%$44.06M-18.6%$54.1M-22.8%
Operating Lease Right-of-Use Assets in Other Assets
$71.5M+66.5%$42.93M-3.7%$44.58M+0.9%$44.2M-3.5%$45.82M-2.3%
Software and Technology Licenses, Net
$33.48M+7.5%$31.14M+4.2%$29.87M+6.3%$28.1M+22.2%$22.99M-11.5%
Accounts payable and other current liabilities (Note 11)
$152.69M+2.9%$148.35M-22.3%$190.84M+14.6%$166.55M-5.3%$175.94M+12.0%
Accrued Income Taxes, Current
$414K+73.2%$239K-95.8%$5.63M+437%$1.05M-93.1%$15.14M+56.7%
Current Portion of Long-Term Debt and Finance Lease Obligations
$1.67M+1.8%$1.64M+77.8%$923K-0.4%$927K+314%$224K-4.3%
Long-Term Debt and Finance Lease Obligations
$609.8M+0.2%$608.75M0.0%$608.58M+0.1%$607.73M+0.6%$603.86M+0.4%
Total debt
$686.61M+4.6%$656.27M-0.1%$657.07M+0.2%$655.84M+0.4%$652.92M+0.3%
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively
$6K0.0%$6K0.0%$6K0.0%$6K0.0%$6K0.0%
Treasury Stock, Value
$438M+7.3%$408.15M+5.3%$387.65M+1.3%$382.85M+11.3%$343.93M+3.4%
Income taxes payable – long-term
$5.93M0.0%$5.93M-14.8%$6.96M0.0%$6.96M0.0%$6.96M0.0%
Finance Lease, Right-of-Use Asset, after Accumulated Amortization
$185K-16.3%$221K-14.7%$259K-12.5%$296K-11.6%$335K-12.5%
Long-Term Debt and Lease Obligation
$609.8M+0.2%$608.75M0.0%$608.58M+0.1%$607.73M+0.6%$603.86M+0.4%
Less: current maturities
$1.67M+1.8%$1.64M+77.8%$923K-0.4%$927K+314%$224K-4.3%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Amphastar Pharmaceuticals's total assets?
Amphastar Pharmaceuticals (AMPH) holds $1.6B in total assets, up 1.4% year over year.
How much cash does Amphastar Pharmaceuticals have?
Amphastar Pharmaceuticals holds $170.9M in cash and equivalents.
Can Amphastar Pharmaceuticals cover its short-term obligations?
Its current ratio is 3.85 — current assets exceed current liabilities.
Where does Amphastar Pharmaceuticals's balance sheet data come from?
Every line is extracted from Amphastar Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.